Analyze Diet

Equine Sarcoids in Captive Wild Equids: Diagnostic and Clinical Management of 16 Cases – A Possible Predisposition of the European Cohort of Somali Wild Ass (Equus africanus somaliensis)?

Abstract: Equine sarcoids (ES) were diagnosed in 12 Somali wild asses (SWA) () from 10 different institutions of the SWA European Endangered Species Programme from 1976 to 2019. Samples of surgically excised masses, biopsies, or necropsy samples were submitted for histologic and virologic analysis. In addition, tissue samples from one onager (), one kulan (), and two Hartmann's mountain zebras (HMZ) () were examined. Histology confirmed the diagnosis of ES exhibiting the typical microscopic features. Polymerase chain reaction detected bovine papillomavirus type 1 (BPV1) DNA in eight SWA samples and bovine papillomavirus type 2 (BPV2) DNA in one SWA sample. The onager, kulan, and one HMZ sample tested positive for BPV1. The other HMZ tested positive for BPV1 and BPV2. This is the first report of ES in an onager. Surgical excision was the treatment elected by most veterinarians. A follow-up survey of the cases over several years after clinical diagnosis and therapy revealed variable individual outcome with ES recurrence in four cases. Three SWA and the kulan were euthanized due to the severity of the lesions. Nine affected SWA were males with seven having a sarcoid located at the prepuce. Because a genetic disposition is a risk factor for the development of ES in horses, this may also be true for endangered wild equids with few founder animals in their studbook history. Innovative approaches regarding therapy and prevention of ES in wild equids are therefore highly encouraged.
Publication Date: 2021-04-09 PubMed ID: 33827158DOI: 10.1638/2020-0166Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The study investigates equine sarcoids (ES), which are skin tumors, in Somali wild asses (SWA) and other wild equids. The research, which spanned over four decades, involved histologic and virologic analysis of the specimens. The health outcomes varied but it was inferred that ongoing research and innovative approaches to treatment and prevention of ES were important.

Objectives of the Study

  • The study aimed to investigate cases of equine sarcoids (ES), a type of skin tumor common in horses, in wild equids — specifically among 12 Somali wild asses (SWA) sourced from 10 different institutions.
  • The researchers also sought to examine specimens from other wild equids like the onager, kulan, and Hartmann’s mountain zebras.
  • The study was designed to use histologic and virologic analysis of surgically removed masses, biopsies, or samples from necropsies.
  • Another objective was to analyze the long-term health outcomes of the affected animals after therapeutic interventions.

Findings

  • The study confirmed the diagnosis of ES in wild equids through histology, which revealed typical microscopic features of the tumor.
  • The virologic analysis detected the presence of bovine papillomavirus type 1 (BPV1) in eight SWA samples and bovine papillomavirus type 2 (BPV2) in one SWA sample. The other wild equids tested positive for either BPV1, BPV2, or both.
  • This study made the first report of an onager being afflicted with ES.

Treatment and Follow-up

  • The primary treatment option used for treating the ES was surgical excision of the tumors, as decided by most veterinarians.
  • A follow-up survey revealed variable health outcomes, with recurrence of ES observed in four cases.
  • Three SWA and one kulan had to be euthanized due to the severity of the lesions caused by the tumors.

Implications

  • The preponderance of this disease chiefly among male SWA, with seven out of nine male SWA having a sarcoid at the prepuce, pointed toward a possible genetic predisposition to ES. This raises concerns about the risks to endangered wild equids with few founders in their lineage.
  • Given these risks, the study called for innovative therapeutic approaches to ES, as well as research directed toward ES prevention in wild equids.

Cite This Article

APA
Wenker C, Hoby S, Steck BL, Ramsauer AS, Blatter S, Tobler K. (2021). Equine Sarcoids in Captive Wild Equids: Diagnostic and Clinical Management of 16 Cases – A Possible Predisposition of the European Cohort of Somali Wild Ass (Equus africanus somaliensis)? J Zoo Wildl Med, 52(1), 28-37. https://doi.org/10.1638/2020-0166

Publication

ISSN: 1042-7260
NlmUniqueID: 8915208
Country: United States
Language: English
Volume: 52
Issue: 1
Pages: 28-37

Researcher Affiliations

Wenker, Christian
  • Zoo Basel, 4054 Basel, Switzerland, christian.wenker@zoobasel.ch.
Hoby, Stefan
  • Zoo Basel, 4054 Basel, Switzerland.
Steck, Beatrice L
  • Zoo Basel, 4054 Basel, Switzerland.
Ramsauer, Anna Sophie
  • Institute of Virology, Vetsuisse Faculty, University of Zurich, 8057 Zurich, Switzerland.
Blatter, Sohvi
  • Institute of Animal Pathology, Vetsuisse Faculty, University of Bern, 3012 Bern, Switzerland.
Tobler, Kurt
  • Institute of Virology, Vetsuisse Faculty, University of Zurich, 8057 Zurich, Switzerland.

MeSH Terms

  • Animals
  • Animals, Zoo
  • Bovine papillomavirus 1 / isolation & purification
  • DNA, Viral / genetics
  • DNA, Viral / isolation & purification
  • Endangered Species
  • Equidae
  • Female
  • Genetic Predisposition to Disease
  • Male
  • Neoplasms / veterinary
  • Skin Neoplasms / diagnosis
  • Skin Neoplasms / genetics
  • Skin Neoplasms / pathology
  • Skin Neoplasms / veterinary

References

This article includes 51 references
  1. Ashrafti GH, Piuko K, Burden F, Yuan Z, Gault EA, Müller M, Trawford A, Reid SWJ, Nasir L, Campo MS. Vaccination of sarcoid-bearing donkeys with chimeric virus-like particles of bovine papillomavirus type 1. J Gen Virol 2008;89(Pt 1):148–157.
  2. Berruex F, Gerber V, Wohlfender FD, Burger D, Koch C. Clinical course of sarcoids in 61 Franches-Montagnes horses over a 5–7 year period. Vet Q 2016; 36(4):189–196.
  3. Brandt S, Haralambus R, Shafti-Keramat S, Steinborn R, Stanek C, Kirnbauer R. A subset of equine sarcoids harbours BPV-1-DNA in a complex with L1 major capsid protein. Virology 2008;375(2): 433–441.
  4. Brostrom H, Fahibrink E, Dubath ML, Lazary S. Association between equine leucocyte antigen (ELA) and equine sarcoid tumors in the population of Swedish halfbreeds and some of their families. Vet Immunol Immunopathol 1988;19(3–4):215–223.
  5. Chambers G, Ellsmore VA, O'Brien PM, Reid SW, Love S, Campo MS, Nasir L. Sequence variants of bovine papillomavirus E5 detected in equine sarcoids. Virus Res 2003;96(1–2):141–145.
  6. Christen G, Gerber V, Dolf G, Burger D, Koch C. Inheritance of equine sarcoid disease in Franches-Montagnes horses. Vet J 2014;199(1):68–71.
  7. Christen-Clottu O, Klocke P, Burger D, Straub R, Gerber V. Treatment of clinically diagnosed equine sarcoid with a mistletoe extract (). J Vet Intern Med 2010;24(6):1483–1489.
  8. . Roadmap for the conservation of the African wild ass. Convention on Migratory Species, Technical Series No. 34 c2017 (September 2017).
  9. Epperson ED, Castleman WL. Bovine papillomavirus DNA and S100 profiles in sarcoids and other cutaneous spindle cell tumors in horses. Vet Pathol 2017;54(1):44–52.
  10. Finlay M, Yuan Z, Burden F, Trawford A, Morgan IM, Campo MS, Nasir L. The detection of bovine papillomavirus type 1 DNA in flies. Virus Res 2009;144(1–2):315–317.
  11. Forslund O, Antonsson A, Nordin P, Stenquist B, Göran Hansson B. A broad range of human papillomavirus types detected with a general PCR method suitable for analysis of cutaneous tumours and normal skin. J Gen Virol 1999;80(Pt 9):2437–2443.
  12. Hainisch EK, Brandt S, Shafti-Keramat S, Van den Hoven R, Kirnbauer R. Safety and immunogenicity of BPV-1 L1 virus-like particles in a dose escalation vaccination trial in horses. Equine Vet J 2014;44(1): 107–111.
  13. Hainisch EK, Harnacker J, Shafti-Keramat S, Kirnbauer R, Brandt S. Vaccination with virus-like particles induces long lasting protection from experimentally induced sarcoid-like tumours in horses. Proc British Equine Vet Assoc 2014. p. 15.
  14. Hammer S. Der klinische Fall: Paragenitales equines Sarkoid bei einem Somalischen Wildesel () [The clinical case: Para-genital equine sarcoid in a Somali wild ass ()]. Tierärztl Prax [Vet Pract] 2005; 33(G)188:193–196.
  15. Haralambus R, Burgstaller J, Klukowska-Rötzler J, Steinborn R, Buchinger S, Gerber V, Brandt S. Intralesional bovine papillomavirus DNA loads reflect severity of equine sarcoid disease. Equine Vet J 2010; 42(4):327–331.
  16. Haspeslagh M, Gerber V, Knottenbelt DC, Schüpbach G, Martens A, Koch C. The clinical diagnosis of equine sarcoids—part 2: assessment of case features typical of equine sarcoids and validation of a diagnostic protocol to guide equine clinicians in the diagnosis of equine sarcoids. Vet J 2018; 240(10): 14–18.
  17. Haspeslagh M, Vlaminck L, Martens A. The possible role of in equine sarcoid transmission. Vet J 2018;231(1):8–12.
  18. IUCN. The IUCN Red List of Threatened Species. 2015.
  19. Jandova V, Klukowska-Rötzler J, Dolf G, Janda J, Roosje P, Marti E, Koch C, Gerber V, Swinburne J. Whole genome scan identifies several chromosomal regions linked to equine sarcoid. Schweiz Arch Tierheilkd [Swiss Arch Vet Med] 2012;154(1):19–25.
  20. Knottenbelt DC. A suggested clinical classification for the equine sarcoid. Clin Tech Equine Pract 2005;4(4):278–295.
  21. Knottenbelt DC. The equine sarcoid: why are there so many treatment options?. Vet Clin North Am Equine Pract 2019;25(2):243–262.
  22. Koch C, Martens A, Hainisch EK, Schüpbach G, Gerber V, Haspeslagh M. The clinical diagnosis of equine sarcoid—part 1: assessment of sensitivity and specificity using a multicentre case-based online examination. Vet J 2018;242(12):77–82.
  23. Koch C, Ramsauer AS, Drögemüller M, Ackermann M, Gerber V, Tobler K. Genomic comparison of bovine papillomavirus 1 isolates from bovine, equine and asinine tissue samples. Virus Res 2018;244(1):6–12.
  24. Koshiba M, Ogawa K, Hamazaki S, Sugiyama T, Ogawa O, Kitajima T. The effect of formalin fixation on DNA and the extraction of high-molecular-weight DNA from fixed and embedded tissues. Pathol Res Pract 1993;189(1):66–72.
  25. Lang EM. Die Somaliwildesel, , im Basler Zoo. [Somali wild ass, , in the Zoo Basel]. Zool Gart 1983;53:73–80.
  26. Lange CE, Vetsch E, Ackermann M, Favrot C, Tobler K. Four novel papillomavirus sequences support a broad diversity among equine papillomaviruses. J Gen Virol 2013;94(6):1365–1372.
  27. Lazary S, Marti E, Szalai G, Gaillard C, Gerber H. Studies on the frequency and associations of equine leucocyte antigens in sarcoid and summer dermatitis. Anim Genet 1994;25(1):75–80.
  28. Löhr CV, Juan-Sallés C, Rosas-Rosas A, Paras Garcia A, Garner MM, Teifke JP. Sarcoids in captive zebras (): association with bovine papillomavirus type 1 infection. J Zoo Wildl Med 2005; 36(1):74–81.
  29. Lunardi M, de Alcântar BK, Ortonel RA, Rodrigues WB, Alfieri AF, Alfieri AA. Bovine papillomavirus type 13 DNA in equine sarcoids. J Clin Microbiol 2013;51(7):2167–2171.
  30. Mair TS, Couto CG. The use of cytotoxic drugs in equine practice. Equine Vet Educ 2006;18(3):149–156.
  31. Marais HJ, Nel P, Bertschinger HJ, Schoeman JP, Zimmermann D. Prevalence and body distribution of sarcoids in South African Cape mountain zebra (). J S Afr Vet Assoc 2007;78(3):145–148.
  32. Martens A, De Moor A, Demeulemeester J, Ducatelle R. Histopathological characteristics of five clinical types of equine sarcoid. Res Vet Sci 2000; 69(3):295–300.
  33. Marti E, Lazary S, Antczak DF, Gerber H. Report of the first international workshop on equine sarcoid. Equine Vet J 1993;25(5):397–407.
  34. Mattil-Fritz S, Scharner D, Piuko K, Thönes N, Gissmann L, Müller H, Müller M. Immunotherapy of equine sarcoid: dose-escalation trial for the use of chimeric papillomavirus-like particles. J Gen Virol 2008;89(Pt 1):138–147.
  35. Moehlman PD. Status and action plan for the African wild ass (). Survey and conservation action plan. Equids: zebras, asses and horses 2002. p. 2–10.
  36. Nasir L, Gault E, Morgan IM, Chambers G, Ellsmore V, Campo MS. Identification and functional analysis of sequence variants in the long control region and the E2 open reading frame of bovine papillomavirus 1 isolated from equine sarcoids. Virology 2007; 364(2):355–361.
  37. Nasir L, Reid SW. Bovine papillomavirus gene expression in equine sarcoid tumours. Virus Res 1999; 61(2):171–175.
  38. Nel PJ, Bertschinger H, Williams J, Thompson PN. Descriptive study of an outbreak of equine sarcoid in a population of Cape mountain zebra () in the Gariep Nature Reserve. J S Afr Vet Assoc 2006;77(4):184–190.
  39. Nogueira SA, Torres SM, Malone ED, Diaz SF, Jessen C, Gilbert S. Efficacy of imiquimod 5% cream in the treatment of equine sarcoids: a pilot study. Vet Dermatol 2006;17(4):259–265.
  40. Pohle C. International studbook of the African wild asses No. 1. Berlin: Tierpark Berlin-Friedrichsfelde; 1973.
  41. Rothacker CC, Boyle AG, Levine DG. Autologous vaccination for the treatment of equine sarcoids: 18 cases (2009–2014). Can Vet J 2015;56(7):709–714.
  42. Steck BL. International studbook for the Somali wild ass 2019. 47th ed. Basel (Switzerland): Zoo Basel; 2020.
  43. Taylor S, Haldorson G. A review of equine sarcoid. Equine Vet Educ 2013;25(4):210–216.
  44. Tesfai RT, Owen-Smith N, Parrini F, Moehlman PD. Viability of the critically endangered African wild ass () population on Messir Plateau (Eritrea). J Mammal 2019;100(1):185–191.
  45. Trenfield K, Spradbrow PB, Vanselow B. Sequences of papillomavirus DNA in equine sarcoids. Equine Vet J 1985;17(6):449–452.
  46. Uhlrich C, Langenhorst T, Trunet E. Preliminary results of a sarcoids survey in African equid European Endangered Species Programmes. Veterinary thesis 2016. Ecole Nationale Vétérinaire de Toulouse (France).
  47. Van Dyk E. Detection and characterization of papillomavirus in zebra () and other South African wild species. Thesis (PhD) University of Pretoria (South Africa). 2011.
  48. Van Dyk E, Oosthuizen MC, Bosman AM, Nel P, Zimmermann D, Venter EH. Detection of bovine papillomavirus DNA in sarcoid-affected and healthy free-roaming zebra () populations in South Africa. J Virol Meth 2009;158(1–2):141–151.
  49. Wilford S, Woodward E, Dunkel B. Owners' perception of the efficacy of Newmarket bloodroot ointment in treating equine sarcoids. Can Vet J 2014; 55(7):683–686.
  50. Wobeser BK, Davies JL, Hill JE, Jackson ML, Kidney BA, Mayer MN, Townsend HGG, Allen AL. Epidemiology of equine sarcoids in horses in western Canada. Can Vet J 2010;51(10):1103–1108.
  51. Zhang Z, Schwartz S, Wagner L, Miller W. A greedy algorithm for aligning DNA sequences. J Comput Biol 2000;7(1–2):203–214.

Citations

This article has been cited 2 times.
  1. Liu Y, Xie L, Zhou Y, Zhou L, Bi J, Zheng M, Lan T, Sun W. Human papillomavirus in canine serum: evidence from a Chinese study. Front Vet Sci 2025;12:1511289.
    doi: 10.3389/fvets.2025.1511289pubmed: 40370836google scholar: lookup
  2. Monod A, Koch C, Jindra C, Haspeslagh M, Howald D, Wenker C, Gerber V, Rottenberg S, Hahn K. CRISPR/Cas9-Mediated Targeting of BPV-1-Transformed Primary Equine Sarcoid Fibroblasts. Viruses 2023 Sep 17;15(9).
    doi: 10.3390/v15091942pubmed: 37766348google scholar: lookup